Claudia Lanvers

998 total citations
19 papers, 721 citations indexed

About

Claudia Lanvers is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Hematology. According to data from OpenAlex, Claudia Lanvers has authored 19 papers receiving a total of 721 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Public Health, Environmental and Occupational Health and 6 papers in Hematology. Recurrent topics in Claudia Lanvers's work include Acute Lymphoblastic Leukemia research (6 papers), Acute Myeloid Leukemia Research (5 papers) and Retinoids in leukemia and cellular processes (5 papers). Claudia Lanvers is often cited by papers focused on Acute Lymphoblastic Leukemia research (6 papers), Acute Myeloid Leukemia Research (5 papers) and Retinoids in leukemia and cellular processes (5 papers). Claudia Lanvers collaborates with scholars based in Germany, United States and Netherlands. Claudia Lanvers's co-authors include Joachim Boos, Georg Hempel, Heribert Jürgens, U Peters, João Paulo Vieira Pinheiro, Rob Pieters, Gottfried Blaschke, Lars Riedemann, Antoinette am Zehnhoff‐Dinnesen and Dirk Deuster and has published in prestigious journals such as Analytical Biochemistry, The FASEB Journal and Annals of Oncology.

In The Last Decade

Claudia Lanvers

19 papers receiving 708 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claudia Lanvers Germany 15 310 231 181 136 80 19 721
Candace Graff United States 10 201 0.6× 25 0.1× 189 1.0× 343 2.5× 42 0.5× 15 983
Frédéric Lirussi France 18 365 1.2× 63 0.3× 32 0.2× 79 0.6× 35 0.4× 41 817
W. A. Gahl United States 16 279 0.9× 22 0.1× 654 3.6× 25 0.2× 29 0.4× 27 1.4k
Wen Zhou United States 16 299 1.0× 47 0.2× 54 0.3× 101 0.7× 12 0.1× 37 775
Anjali Pathak India 3 461 1.5× 19 0.1× 23 0.1× 87 0.6× 13 0.2× 8 748
Hongwu Chen China 23 443 1.4× 40 0.2× 30 0.2× 106 0.8× 11 0.1× 149 1.5k
Anna Brózik Hungary 13 291 0.9× 26 0.1× 43 0.2× 212 1.6× 8 0.1× 17 536
Akiko Nishino Japan 12 159 0.5× 36 0.2× 41 0.2× 65 0.5× 7 0.1× 43 609
Zhiying Gao China 16 317 1.0× 61 0.3× 197 1.1× 31 0.2× 6 0.1× 36 859
Erlisa Bardhi Italy 10 162 0.5× 132 0.6× 43 0.2× 137 1.0× 5 0.1× 16 493

Countries citing papers authored by Claudia Lanvers

Since Specialization
Citations

This map shows the geographic impact of Claudia Lanvers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudia Lanvers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudia Lanvers more than expected).

Fields of papers citing papers by Claudia Lanvers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudia Lanvers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudia Lanvers. The network helps show where Claudia Lanvers may publish in the future.

Co-authorship network of co-authors of Claudia Lanvers

This figure shows the co-authorship network connecting the top 25 collaborators of Claudia Lanvers. A scholar is included among the top collaborators of Claudia Lanvers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudia Lanvers. Claudia Lanvers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
2.
Verschuur, Arnauld, et al.. (2008). 193 POSTER Preclinical evaluation of the marine compound PM00104 within the ITCC pediatric tumor cell line panel in vitro and in vivo. European Journal of Cancer Supplements. 6(12). 61–61. 1 indexed citations
3.
Koling, Susanne, Georg Hempel, Claudia Lanvers, Joachim Boos, & Gudrun Würthwein. (2007). Monitoring paracetamol metabolism after single and repeated administration in pediatric patients with neoplastic diseases. International Journal of Clinical Pharmacology and Therapeutics. 45(9). 496–503. 5 indexed citations
4.
Riedemann, Lars, Claudia Lanvers, Dirk Deuster, et al.. (2007). Megalin genetic polymorphisms and individual sensitivity to the ototoxic effect of cisplatin. The Pharmacogenomics Journal. 8(1). 23–28. 86 indexed citations
5.
Lanvers, Claudia, Dirk Reinhardt, Angelika Dübbers, et al.. (2003). Pharmacology of all‐trans‐retinoic acid in children with acute promyelocytic leukemia. Medical and Pediatric Oncology. 40(5). 293–301. 20 indexed citations
6.
Lanvers, Claudia, et al.. (2002). Analytical validation of a microplate reader-based method for the therapeutic drug monitoring of l-asparaginase in human serum. Analytical Biochemistry. 309(1). 117–126. 75 indexed citations
7.
Schuck, Andreas, Christopher Poremba, Claudia Lanvers, et al.. (2002). Radiation-Induced Changes of Telomerase Activity in a Human Ewing Xenograft Tumor. Strahlentherapie und Onkologie. 178(12). 701–708. 15 indexed citations
8.
Würthwein, Gudrun, et al.. (2002). Population pharmacokinetics of high-dose etoposide in children receiving different conditioning regimens. Anti-Cancer Drugs. 13(1). 101–110. 14 indexed citations
9.
Poremba, Christopher, Bernhard Heine, Raihanatou Diallo, et al.. (2002). Telomerase as a prognostic marker in breast cancer: high‐throughput tissue microarray analysis of hTERT and hTR. The Journal of Pathology. 198(2). 181–189. 106 indexed citations
10.
Hotfilder, Marc, Claudia Lanvers, Heribert Jürgens, Joachim Boos, & Josef Vormoor. (2002). c-KIT-expressing Ewing tumour cells are insensitive to imatinib mesylate (STI571). Cancer Chemotherapy and Pharmacology. 50(2). 167–169. 30 indexed citations
11.
Müller, Hans‐Joachim, Rita Beier, Claudia Lanvers, et al.. (2001). PEG-asparaginase (Oncaspar) 2500 U/m2 BSA in reinduction and relapse treatment in the ALL/NHL-BFM protocols. Cancer Chemotherapy and Pharmacology. 49(2). 149–154. 28 indexed citations
12.
Ahlmann, Martina, et al.. (2001). Modulation of ara-CTP levels by fludarabine and hydroxyurea in leukemic cells. Leukemia. 15(1). 69–73. 2 indexed citations
13.
Peters, U, Sabine Preisler-Adams, Matthias Hahn, et al.. (2000). Glutathione S-transferase genetic polymorphisms and individual sensitivity to the ototoxic effect of cisplatin. Anti-Cancer Drugs. 11(8). 639–643. 99 indexed citations
14.
Schroeter, Thomas, et al.. (2000). Pseudotumor cerebri induced by all-trans-retinoic acid in a child treated for acute promyelocytic leukemia. Medical and Pediatric Oncology. 34(4). 284–286. 17 indexed citations
15.
Dübbers, Angelika, Gudrun Würthwein, H.-J. Müller, et al.. (2000). Asparagine synthetase activity in paediatric acute leukaemias: AML‐M5 subtype shows lowest activity. British Journal of Haematology. 109(2). 427–429. 41 indexed citations
16.
Lanvers, Claudia, et al.. (2000). Determination of purines including 2,8-dihydroxyadenine in urine using capillary electrophoresis. Journal of Chromatography A. 894(1-2). 157–164. 33 indexed citations
18.
Lanvers, Claudia, Georg Hempel, Gottfried Blaschke, & Joachim Boos. (1998). Chemically induced isomerization and differential uptake modulate retinoic acid disposition in HL‐60 cells. The FASEB Journal. 12(15). 1627–1633. 23 indexed citations
19.
Lanvers, Claudia, Georg Hempel, Gottfried Blaschke, & Joachim Boos. (1996). Simultaneous determination of all-trans-, 13-cis- and 9-cis-retinoic acid, their 4-oxo metabolites and all-trans-retinol in human plasma by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 685(2). 233–240. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026